FDA rejects MDMA-assisted therapy for PTSD in a setback for psychedelic medicine
The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.
The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.